This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignees: Republic of Korea (Minister of Food and Drug Safety), Yonsei University. Active years: 2025.
Company Filing History:
1 out of 2 
1 out of 1,478 
Years Active: 2025
Title: Bo Ryeong Lee: Innovator in Cancer Treatment
Introduction
Bo Ryeong Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment, particularly in the area of non-small cell lung cancer. His innovative approaches have the potential to enhance therapeutic responses in patients undergoing cancer immunotherapy.
Latest Patents
Bo Ryeong Lee holds 1 patent related to methods for treating non-small lung cancer and for preparing a sample. This patent discloses a method for providing information on a therapeutic reaction of cancer immunotherapy. The method involves measuring the expression levels of PD-L1 and PVR in a biological sample isolated from a subject. Based on these measurements, the therapeutic reaction of cancer immunotherapy for the subject can be evaluated.
Career Highlights
Throughout his career, Bo Ryeong Lee has worked with esteemed institutions, including Yonsei University and the Republic of Korea's Ministry of Food and Drug Safety. His work in these organizations has allowed him to contribute to advancements in medical research and regulatory practices.
Collaborations
Bo Ryeong Lee has collaborated with notable colleagues, including Sang Jun Ha and Hye Ryun Kim. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Bo Ryeong Lee's contributions to cancer treatment through his innovative patent and collaborations with esteemed institutions highlight his commitment to advancing medical science. His work has the potential to significantly impact the field of cancer immunotherapy.